Search research articles
Contact Us
Filters
Showing results (31-40 of 54) with videos related to
Page
of 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2018
Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma
Jing Huang, Binghe Xu, Hongnan Mo, et al.
Cancer Biology & Medicine
|
September 13, 2024
Clinical benefit and safety profile of cross-line therapy with CDK4/6 inhibitors: a retrospective study of HR+/HER2- advanced breast cancer
Qi Zhao, Mingxia Jiang, Jiaxuan Liu, et al.
JAMA Network Open
|
November 2, 2022
Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer
Hongnan Mo, Xiaoyan Yan, Fang Zhao, et al.
British Journal of Cancer
|
May 15, 2018
Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study
Hongnan Mo, Jing Huang, Jiachen Xu, et al.
Nature Medicine
|
July 5, 2024
Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial
Hongnan Mo, Yongpei Yu, Xiaoying Sun, et al.
Breast (Edinburgh, Scotland)
|
September 24, 2023
Safety and efficacy study of oral metronomic capecitabine combined with pyrotinib in HER2-positive metastatic breast cancer: A phase II trial
Maiyue He, Jiaxuan Liu, Zijing Wang, et al.
Cancer
|
December 4, 2018
Promising efficacy of SHR-1210, a novel anti-programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in China
Jing Huang, Hongnan Mo, Weilong Zhang, et al.
Therapeutic Advances in Medical Oncology
|
January 5, 2026
Efficacy and safety of PARP inhibitors in metastatic breast cancer patients with homologous recombination repair pathway gene mutations: a retrospective multicenter real-world study
Xuenan Peng, Ruixia Song, Ying Fan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
July 13, 2023
MTA1, a Novel ATP Synthase Complex Modulator, Enhances Colon Cancer Liver Metastasis by Driving Mitochondrial Metabolism Reprogramming
Ting Wang, Fangzhou Sun, Chunxiao Li, et al.
International Journal of Cancer
|
June 27, 2020
Platinum-based chemotherapy in advanced triple-negative breast cancer: A multicenter real-world study in China
Yimeng Chen, Yin Guan, Jiayu Wang, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 54) with videos related to
Sort By:
Page
of 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2018
Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma
Jing Huang, Binghe Xu, Hongnan Mo, et al.
Cancer Biology & Medicine
|
September 13, 2024
Clinical benefit and safety profile of cross-line therapy with CDK4/6 inhibitors: a retrospective study of HR+/HER2- advanced breast cancer
Qi Zhao, Mingxia Jiang, Jiaxuan Liu, et al.
JAMA Network Open
|
November 2, 2022
Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer
Hongnan Mo, Xiaoyan Yan, Fang Zhao, et al.
British Journal of Cancer
|
May 15, 2018
Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study
Hongnan Mo, Jing Huang, Jiachen Xu, et al.
Nature Medicine
|
July 5, 2024
Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial
Hongnan Mo, Yongpei Yu, Xiaoying Sun, et al.
Breast (Edinburgh, Scotland)
|
September 24, 2023
Safety and efficacy study of oral metronomic capecitabine combined with pyrotinib in HER2-positive metastatic breast cancer: A phase II trial
Maiyue He, Jiaxuan Liu, Zijing Wang, et al.
Cancer
|
December 4, 2018
Promising efficacy of SHR-1210, a novel anti-programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in China
Jing Huang, Hongnan Mo, Weilong Zhang, et al.
Therapeutic Advances in Medical Oncology
|
January 5, 2026
Efficacy and safety of PARP inhibitors in metastatic breast cancer patients with homologous recombination repair pathway gene mutations: a retrospective multicenter real-world study
Xuenan Peng, Ruixia Song, Ying Fan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
July 13, 2023
MTA1, a Novel ATP Synthase Complex Modulator, Enhances Colon Cancer Liver Metastasis by Driving Mitochondrial Metabolism Reprogramming
Ting Wang, Fangzhou Sun, Chunxiao Li, et al.
International Journal of Cancer
|
June 27, 2020
Platinum-based chemotherapy in advanced triple-negative breast cancer: A multicenter real-world study in China
Yimeng Chen, Yin Guan, Jiayu Wang, et al.
Page
of 6